BDMD (Baird Medical Investment Holdings) Beginning Cash Position: $2.17 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDMD Baird Medical Investment Holdings Ltd BDMD
17 GF Score
Price $1.06
! 7 Warning Signs
View Full Analysis

What is Baird Medical Investment Holdings Beginning Cash Position?

Baird Medical Investment Holdings BDMD -2.86% 17 Beginning Cash Position is $2.17 Mil as of Dec. 2025. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review.

Baird Medical Investment Holdings's Beginning Cash Position for the quarter that ended in Dec. 2025 was $2.17 Mil.

Baird Medical Investment Holdings's quarterly Beginning Cash Position increased from Dec. 2024 ($1.50 Mil) to Jun. 2025 ($2.97 Mil) but then declined from Jun. 2025 ($2.97 Mil) to Dec. 2025 ($2.17 Mil).

Baird Medical Investment Holdings's annual Beginning Cash Position declined from Dec. 2023 ($1.71 Mil) to Dec. 2024 ($1.51 Mil) but then increased from Dec. 2024 ($1.51 Mil) to Dec. 2025 ($2.97 Mil).

Baird Medical Investment Holdings Beginning Cash Position Related Terms

Baird Medical Investment Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Baird Medical Investment Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings Beginning Cash Position Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
1.07 3.03 1.71 1.51 2.97

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial 0.54 1.51 1.50 2.97 2.17
BDMD
17GF Score
Baird Medical Investment Holdings Ltd BDMD
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baird Medical Investment Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $2.17 Mil mean?
Baird Medical Investment Holdings (BDMD) has a Beginning Cash Position of $2.17 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Baird Medical Investment Holdings and its competitors.
Is Baird Medical Investment Holdings' Beginning Cash Position too high?
Baird Medical Investment Holdings' current Beginning Cash Position is $2.17 Mil. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Beginning Cash Position compare to TELA and NSPR?
Baird Medical Investment Holdings' Beginning Cash Position of $2.17 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Baird Medical Investment Holdings and its competitors. Baird Medical Investment Holdings's current Beginning Cash Position is $2.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Beginning Cash Position of $2.17 Mil. The current Beginning Cash Position is $2.17 Mil. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Beginning Cash Position is $2.17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baird Medical Investment Holdings Business Description

Address No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu District, Guangzhou, CHN
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score

Get the complete analysis for BDMD

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.06
Price